SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0000903423-18-000570
Filing Date
2018-10-25
Accepted
2018-10-25 16:52:05
Documents
1

Document Format Files

Seq Description Document Type Size
1 allogene.htm SC 13D 103961
  Complete submission text file 0000903423-18-000570.txt   105486
Mailing Address C/O TPG GLOBAL, LLC 301 COMMERCE STREET, SUITE 3300 FORT WORTH TX 76102
Business Address C/O TPG GLOBAL, LLC 301 COMMERCE STREET, SUITE 3300 FORT WORTH TX 76102 817-871-4000
TPG Group Holdings (SBS) Advisors, Inc. (Filed by) CIK: 0001495741 (see all company filings)

IRS No.: 271650453 | State of Incorp.: DE
Type: SC 13D

Mailing Address 210 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 210 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080 (650) 457-2700
Allogene Therapeutics, Inc. (Subject) CIK: 0001737287 (see all company filings)

IRS No.: 823562771 | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-90685 | Film No.: 181139464
SIC: 2836 Biological Products, (No Diagnostic Substances)